leisure time -WSS

leisure time

author：entertainment 2025-09-29 01:07:41 - browse：19437

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Rise in cancer among younger people worries and puzzles doctors

Wikipedia

WSS

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Medicare Advantage overpayments discussion gets experts fired up

Life science postdocs should get big pay hike, NIH panel says

Arena BioWorks launches in Cambridge to speed drug discovery

American taxpayers paid $1.8 trillion in health care costs in 2022

CDC Director Mandy Cohen on transparency, trust, and health

focus

leisure time

leisure time

The high cost of giving birth even with insurance

Merck to acquire Harpoon Therapeutics for $680 million

After affirmative action ruling, medical educators look to 'holistic review'

Profiling embryos to choose those with higher IQs is almost a reality

Cancer drug shortages should be causing more outrage

Profiling embryos to choose those with higher IQs is almost a reality

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Nonprofit, backed by Microsoft, to certify AI tools in health care

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare Advantage overpayments discussion gets experts fired up

hotspot

Why patients can’t get everything they want on drug pricing

Physician assistants need a new name. Here's what it should be

'Investigate these claims': UFO transparency at center of House hearing

A preacher's new calling: Diversifying neuroscience research

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Medicare Advantage overpayments discussion gets experts fired up

hotspot

Wikipedia

Wikipedia

hotspot